-
Opinion: How Pharma Can Fix Its Reputation and Its Business at the Same Time
The business model of research-based pharmaceutical companies is under significant pressure. Their return on R&D investment has dropped to its lowest levels in decades, and their public reputation in the United States and abroad is worse than ever.
- Categories
- Health Care
- Region
- North America
- Tags
- public health
-
How Wealthy Private Investors Might Save Climate Research
President Trump has made sweeping changes in his first week in office. Scientific research—specifically environmental programs—have seen a huge hit. The new administration quietly froze all Environment Protection Agency (EPA) grants, as well as ordered a gag order on any employees from going public about it.
- Categories
- Environment
- Region
- North America
- Tags
- public policy
-
Profits? Nice, but for These Investors, Conscience Matters More
Seth Holehouse, who owns an auction house in New York City, has focused his investments on renewable energy and recycled products. He has done so for the last five years — despite steadily losing money on the strategy.
- Categories
- Impact Assessment, Investing
- Region
- North America
-
Clinton Foundation President Donna Shalala talks finances, focus and the future
Describing the past 18 months as “intense” and “challenging,” Clinton Foundation President Donna Shalala was eager to reassure that the foundation is “alive and well and thriving” in a call with a small group of reporters on Friday. “Rumors of our demise are greatly exaggerated,” she said.
- Categories
- Impact Assessment, Investing
- Region
- North America
-
Trump vows to get drug prices lower, tells drugmakers he wants them to manufacture in the US
President Donald Trump met with leading drugmakers at the White House on Tuesday, jawboning them to produce their medications in the United States and to cut "astronomical" drug prices.
- Categories
- Health Care
- Region
- North America
-
New Startup Accelerator For Social Entrepreneurs Targeting Climate Change And Water Systems
Social entrepreneurs fighting climate change: There’s a new accelerator that might be for you. Called Climate Ventures 2.0, it’s run by GoodCompany Ventures, a Philadelphia-based social enterprise accelerator, and will accept 10 startups aimed specifically at addressing climate-related threats to agriculture and the resilience of water systems.
- Categories
- Impact Assessment
- Region
- North America
-
The $12 Trillion Opportunity Ripe for Investing Dollars: Advancing Gender Equality
On Saturday, more than three million people around the country — that’s one out of every 100 Americans — and upwards of another 250,000 people around the world marched in the name of gender equality. On Sunday, many of those same people woke up and asked, “What’s next?” Supporters have posted lists and guides for for the weeks and months ahead, but for those who might want to literally put their money where their mouths are, a new report from BNY Mellon and the United Nations Foundation serves as an alternative template. Its key suggestion: simultaneously accelerate progress and tap into a multi-trillion dollar opportunity by investing in companies that are gender-diverse, led by women, or providing services that help advance gender equality.
- Categories
- Impact Assessment, Investing
- Region
- North America
-
Climate Ventures 2.0 Launches With $250K Available for Ag and Water System Resilience
GoodCompany Ventures is pleased to announce the public launch of Climate Ventures 2.0, a global accelerator focused on Agriculture and Water Systems Resilience, and its call for applications for $250,000 of GCV Impact Grants.
- Categories
- Impact Assessment, Investing
- Region
- North America
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.